Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical is the largest player in the promising field of robotic-assisted surgery. The company routinely delivers excellent financials and benefits from a strong moat.

1 No-Brainer Growth Stock to Buy and Hold for 10 Years

Netflix

Surgical robotics and media streaming represent two rapidly growing and evolving industries. Intuitive Surgical just garnered a new regulatory approval, and profits are soaring.

2 Magnificent Growth Stocks to Add to Your Buy Basket in the New Nasdaq Bull Market

Pinterest

Artificial intelligence (AI) has the potential to be the biggest game-changer for the global economy since the advent of the internet. Despite being a direct beneficiary of the rise of AI, history is not on Nvidia's side.

Forget Nvidia: Billionaires Are Selling It and Piling Into 2 Rapidly Growing Artificial Intelligence (AI) Stocks Instead

Deere & Company

NVIDIA

Rockwell Automation

Teradyne

Thermo Fisher Scientific

Tesla

Investors seeking reliable AI-powered returns should consider robotics stocks. Many companies are leveraging artificial intelligence to create human-like robots.

7 Robotics Stocks to Bet On for Reliable AI-Powered Returns

Garrett Motion

Iridium Communications

Lithium Americas Argentina Corp

Sirius XM Holdings Inc

SharkNinja Inc

Titan Machinery

Finding value stocks to buy — especially if you're trying to emulate Warren Buffett — isn't nearly as easy as copying trades from Berkshire Hathaway (NYSE: BRK-A , NYSE: BRK-B ). Something many amateur Buffett aficionados overlook is that, when it comes to finding value stocks to buy, Warren Buffett's choices are surprisingly slim.

7 Timeless Value Stocks to Build Wealth Like Warren Buffett

Raytheon Technologies

Once confined to sci-fi movies and dreamers, robotics stocks have revolutionized what's possible. These companies have transformed industries from manufacturing to healthcare, creating efficiencies in areas where humans simply can't achieve a certain level of precision.

3 Robotics Stocks That Could Be Multibaggers in the Making: Spring Edition

Symbotic Inc

Zebra Technologies

Robotics stocks are leading today's tech frontier. There are very few areas where robotics will not create a huge impact, which is why projections indicate the market size will reach a value of approximately $43 billion by 2024.

Shhh! 3 Secret Robotics Stocks Flying Below Wall Street's Radar

Robotic surgery isn't the future — it's here. And, as rivalries mount, Intuitive Surgical has launched what doctors call a "game-changer.

Intuitive Surgical Builds On Its Robotic Surgery Prowess. But Challengers Are Coming.

Apple

AMC Entertainment

Advanced Micro Devices

Amazon

Chipotle

ConocoPhillips

Carvana

eBay

Etsy

VanEck Vectors Gold Miners ETF

GameStop

McDonald's

Moderna

Microsoft

QUALCOMM

Starbucks

Super Micro Computer

Snap

Spotify

Stanley Black & Decker

Large-cap growth funds have been in the sweet spot for a few years now, thanks to megacap tech holdings.

Highly ranked manager who bet on Mag 7 giants looks to these second-order winners from AI

Align Technology

Johnson & Johnson

Undoubtedly, investors seem to have a new appetite for next-level revenue growth. Generative AI, GLP-1 weight-loss drugs and other breakthrough innovations (I'm not sure if the metaverse qualifies right now) seek to expand in some pretty massive markets.

Cutting Edge Picks: 3 Med Tech Stocks With Room to Run

UiPath

Robotics has moved far before the realm of science fiction, revolutionizing industries from manufacturing to healthcare. The robotics market is booming, and investors can benefit from the enormous potential of robotics stocks.

3 Robotics Stocks That Will Make Early Investors Exceedingly Wealthy

DexCom

Masimo

The value of the “global medical device market” is expected to jump from over $500 billion last year to nearly $800 billion “by 2030.” According to the World Health Organization, “a medical device can be any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or other similar or related article.

Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024

DaVita

HCA Healthcare

The healthcare industry is one of the biggest in the United States and other countries. In the US, the total Medicare expenditure stood at over $927 billion in 2022 and the trend is continuing as the population ages.

Best blue chip healthcare stocks to buy and hold in 2024

Intuitive Surgical Intuitive Surgical (NASDAQ NASDAQ : ISRG) recently reported its Q1 results, with revenues and earnings beating the street estimates. The company reported revenue of $1.89 billion and adjusted earnings of $1.50 per share, compared to the consensus estimates of $1.87 billion and $1.41, respectively.

Should You Pick Intuitive Surgical Stock At $370?

While artificial intelligence (AI) and robots are in the spotlight regularly these days, there's a company that's been making surgical robots for over two decades. Intuitive Surgical Inc. NASDAQ: ISRG is the pioneer in robotic-assisted surgical systems.

Intuitive Surgical Leads the Robotic Surgery Movement

Intuitive Surgical outperformed analyst expectations for both EPS and revenue for Q1. Regulatory approvals for da Vinci 5 and a single-port surgical system set the stage for expansion.

Intuitive Surgical's Q1 Earnings: A Robotic Surge

If you wonder if Intuitive Surgical NASDAQ: ISRG stock can trend higher this year, it can. The med tech business is growing, and Intuitive Surgical is the industry leader and outperforming expectations.

Intuitive Surgical Stock Can Trend Much Higher This Year

Intuitive Surgical's (ISRG) first-quarter results reflect a healthy demand for procedures. Higher pricing boosts procedure sales.

Intuitive Surgical (ISRG) Q1 Earnings Beat, Procedures Robust

Bristol-Myers

Novo Nordisk

Healthcare stocks can be excellent choices for investors, offering a balance of safety and growth. Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk all have strong growth potential.

Got $500? 3 Healthcare Stocks to Buy and Hold Forever

Shares in Intuitive Surgical (ISRG) jumped more than 3% in after-hours Thursday after surpassing analysts' earnings and revenue forecasts amid growing demand for the company's robotics solutions used in minimally invasive medical procedures.

Intuitive Surgical Stock Jumps After Q1 Earnings Beat Amid da Vinci Robotic System Growth

Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q1 2024 Earnings Conference Call April 18, 2024 4:30 PM ET Company Participants Brian King - Head of Investor Relations Gary Guthart - Chief Executive Officer Jamie Samath - Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Travis Steed - Bank of America Rick Wise - Stifel Adam Maeder - Piper Sandler Drew Ranieri - Morgan Stanley Matt Miksic - Barclays Brandon Vazquez - William Blair Jayson Bedford - Raymond James Operator Thank you everyone for standing by and welcome to the Intuitive Q1 2024 Earnings Release Call. At this time, all participants are on a listen-only mode.

Intuitive Surgical, Inc. (ISRG) Q1 2024 Earnings Call Transcript

The headline numbers for Intuitive Surgical (ISRG) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Intuitive Surgical (ISRG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Taiwan Semiconductor Manufacturing

Netflix, Taiwan Semi and Intuitive Surgical all handily beat Q1 estimates, but only one is trading in the green this afternoon.

Big Q1 Beats After the Close; Markets Struggle to Gain

Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $1.50 per share, beating the Zacks Consensus Estimate of $1.40 per share. This compares to earnings of $1.23 per share a year ago.

Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Top Estimates

Intuitive Surgical beat Wall Street estimates for first-quarter profit and revenue on Thursday, riding on higher demand for its robots used in minimally invasive procedures.

News for Intuitive Surgical Stock (ISRG)